Emergency anticancer therapy in intensive care medicine: A mainland China survey
By: Hao Zhang, DongHao Wang, ChangSong Wang and Xue-Zhong Xing
References
- Azoulay E, Schellongowski P, Darmon M, et al. The Intensive Care Medicine research agenda on critically ill oncology and hematology patients. Intensive Care Med. 2017; 43:1366–1382. doi: 10.1007/s00134-017-4884-z.
- Lafarge A, Chean D, Whiting L, et al; Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH); Clinical Research in Intensive Care and Sepsis - TRIal Group for Global Evaluation and Research in SEPsis (CRICS-TRIGGERSEP). Management of hematological patients requiring emergency chemotherapy in the intensive care unit. Intensive Care Med. 2024; 50:849–860. doi: 10.1007/s00134-024-07454-z.
- Wang HJ, Chen W, Wang HZ, et al; Critical Care Medicine Committee of Beijing Association of Oncology (CCMBAO). Expert Consensus on Acute Respiratory Failure in Critically Ill Cancer Patients (2023). Chin Med Sci J. 2023; 38:163–177. doi: 10.24920/004203.
- Shaz DJ, Pastores SM, Goldman DA, et al. Characteristics and outcomes of patients with solid tumors receiving chemotherapy in the intensive care unit. Support Care Cancer. 2020, 28:3855–65. 10.1007/s00520-019-05226-w.
- Bredin S, Decroocq J, Devautour C, et al. Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies. Ann Intensive Care. 2024; 14:143. doi: 10.1186/s13613-024-01372-5.
- Darmon M, Thiery G, Ciroldi M, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med. 2005;33(11):2488–93. doi: 10.1097/01.ccm.0000181728.13354.0a.
- Matuszkiewicz-Rowinska J, Malyszko J. Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress. Kidney Blood Press Res. 2020;45(5):645–660. doi: 10.1159/000509934.
- Darmon M, Guichard I, Vincent F, et al. Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leuk Lymphoma. 2010;51(2):221–7. doi: 10.3109/10428190903456959.
- Zafrani L, Canet E, Darmon M. Understanding tumor lysis syndrome. Intensive Care Med. 2019;45(11):1608–1611. doi: 10.1007/s00134-019-05768-x.
- Aggarwal A, Mahajan D, Sharma P. Application of the International Society on Thrombosis and Haemostasis Scoring System in Evaluation of Disseminated Intravascular Coagulation in Patients with Acute Leukemias. South Asian J Cancer. 2021;10(4):241–245. doi: 10.1055/s-0041-1733347.
- Wang TF, Makar RS, Antic D, Let al. Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH. J Thromb Haemost. 2020;18(12):3174–3183. doi: 10.1111/jth.15074.
- Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol. 2015;168(1):63–8. doi: 10.1111/bjh.13102.
- La Rosée P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–2477. doi: 10.1182/blood.2018894618.
- Stahl M, Shallis RM, Wei W, et al. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study. Leukemia. 2020;34(12):3149–3160. doi: 10.1038/s41375-020-0783-3.
- Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345–1377. doi: 10.1182/blood.2022016867.
- Shaz D, Pastores SM, Dayal L, et al. Analysis of Intent and Reason for Oncologic Therapy Administration in Cancer Patients Admitted to the Intensive Care Unit. J Intensive Care Med. 2022;37(10):1305–1311. doi: 10.1177/08850666211065993.
- Zerbib Y, Rabbat A, Fartoukh M, et al; Groupe de Recherche sur la Réanimation Respiratoire en Onco-Hématologie (GRRR-OH). Urgent Chemotherapy for Life-Threatening Complications Related to Solid Neoplasms. Crit Care Med. 2017;45(7):e640–e648. doi: 10.1097/CCM.0000000000002331.
- Louie AV, Lane S, Palma DA, et al. Radiotherapy for intubated patients with malignant airway obstruction: futile or facilitating extubation? J Thorac Oncol. 2013;8(11):1365–70. doi: 10.1097/JTO.0b013e3182a47501.
- Lee IH, Yang CY, Shih JY, et al. Tyrosine Kinase Inhibitors Improved Survival of Critically Ill EGFR-Mutant Lung Cancer Patients Undergoing Mechanical Ventilation. Biomedicines. 2021;9(10):1416. doi: 10.3390/biomedicines9101416.
- Soares M, Bozza FA, Azevedo LC, et al Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care Units. J Clin Oncol. 2016;34(27):3315–24. doi: 10.1200/JCO.2016.66.9549.
- Song JH, Kim S, Lee HW, et al. Effect of intensivist involvement on clinical outcomes in patients with advanced lung cancer admitted to the intensive care unit. PLoS One. 2019;14(2):e0210951. doi: 10.1371/journal.pone.0210951.
Language: English
Page range: 438 - 443
Submitted on: Jun 27, 2025
Accepted on: Jan 21, 2026
Published on: Jul 27, 2026
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Hao Zhang, DongHao Wang, ChangSong Wang, Xue-Zhong Xing, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.